×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PLRZ – polyrizon ltd. - ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PLRZ
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/13
07:51 am
plrz
Polyrizon Launches Preclinical Studies for Intranasal Naloxone to Combat Opioid Overdose Using Cutting-Edge Platform
Medium
Report
Polyrizon Launches Preclinical Studies for Intranasal Naloxone to Combat Opioid Overdose Using Cutting-Edge Platform
3/11
04:27 pm
plrz
Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024
High
Report
Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024
3/10
07:47 am
plrz
Polyrizon Initiates Preclinical Studies for Intranasal Naloxone Targeting Opioid Overdose Based on Its Innovative T&T Platform
Medium
Report
Polyrizon Initiates Preclinical Studies for Intranasal Naloxone Targeting Opioid Overdose Based on Its Innovative T&T Platform
1/30
05:55 am
plrz
Polyrizon Announces Filing of Divisional Patent Application for Its Innovative Trap & Target™ (T&T) Intranasal Drug Delivery Platform
Medium
Report
Polyrizon Announces Filing of Divisional Patent Application for Its Innovative Trap & Target™ (T&T) Intranasal Drug Delivery Platform
1/23
06:40 am
plrz
Polyrizon Commences GMP Manufacturing Preliminary Process for its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial
Medium
Report
Polyrizon Commences GMP Manufacturing Preliminary Process for its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial
12/30
06:25 am
plrz
Polyrizon Announces Publication of U.S. National Patent Application for Its Innovative Hydrogel Nasal Technologies
High
Report
Polyrizon Announces Publication of U.S. National Patent Application for Its Innovative Hydrogel Nasal Technologies
12/19
07:22 am
plrz
Polyrizon Appoints Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs
High
Report
Polyrizon Appoints Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs
12/18
06:25 am
plrz
Polyrizon's Moving Forward with Expected 2025 Clinical Trial - Entered Manufacturing Agreement for its PL-14 Allergy Blocker
High
Report
Polyrizon's Moving Forward with Expected 2025 Clinical Trial - Entered Manufacturing Agreement for its PL-14 Allergy Blocker
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/11
04:06 pm
plrz
Form 20-F Polyrizon Ltd. For: Dec 31
Medium
Report
Form 20-F Polyrizon Ltd. For: Dec 31
3/10
05:00 pm
plrz
Form 6-K Polyrizon Ltd. For: Mar 10
Medium
Report
Form 6-K Polyrizon Ltd. For: Mar 10
3/5
04:00 pm
plrz
Form SCHEDULE 13G Polyrizon Ltd. Filed by: Izraeli Tomer
Medium
Report
Form SCHEDULE 13G Polyrizon Ltd. Filed by: Izraeli Tomer
1/30
06:06 am
plrz
Form 6-K Polyrizon Ltd. For: Jan 30
High
Report
Form 6-K Polyrizon Ltd. For: Jan 30
1/23
08:59 am
plrz
Form 6-K Polyrizon Ltd. For: Jan 23
Medium
Report
Form 6-K Polyrizon Ltd. For: Jan 23
1/21
04:15 pm
plrz
Form 6-K Polyrizon Ltd. For: Jan 21
Medium
Report
Form 6-K Polyrizon Ltd. For: Jan 21
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: